[其他期刊] [补充材料]First-Line Apatinib Combined with Tislelizumab and Chemotherapy for Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma with Poor Prognosis 求助已关闭
|
20
20
20
20
20
